With this call ERA PerMed wants to encourage and enable interdisciplinary collaborations towards the implementation of PM, by combining pre-clinical and/or clinical research with computational components and research on relevant ethical, legal and social aspects (ELSI) and/or research on the optimisation of the health care systems. Patient and citizen empowerment and training strategies for the different stakeholders in PM are new modules in this third call. The available budget for this call is 24.6 Mio € (approx.).
You can find further information on the call on the ERA PerMed website.
“ERA PerMed” – ERA-Net on Personalised Medicine
ERA PerMed (2017-2022) is an ERA-Net Cofund Action on Personalised Medicine (PM), supported by 32 partners of 23 countries and co-funded by the European Commission (EC) via Horizon 2020. It aims to align national and regional research strategies and funding activities, promoting excellence, reinforcing the competitiveness of European players in PM, and enhance the collaboration with non-EU countries by conducting together up to 4 Joint Transnational Calls (JTC). The JTC in 2020 represents the second of up to three additional calls not co-funded by the EC.
ERA PerMed is closely linked to ICPerMed. It will foster the implementation of the ICPerMed Action Plan by funding transnational research projects in the field of PM.
Please visit the ERA PerMed website on: www.erapermed.eu